Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted.

Ward, K; Spurr, L; Goldman, NR; Margaritopoulos, GA; Kokosi, M; Renzoni, E; Chua, F; Ward, K; Spurr, L; Goldman, NR; Margaritopoulos, GA; Kokosi, M; Renzoni, E; Chua, F; Maher, TM; Ward, S; Wells, AU; - view fewer (2016) Patient eligibility for anti-fibrotic therapy in idiopathic pulmonary fibrosis can be altered by use of different sets of reference values for calculation of FVC percent predicted. Respir Med , 120 pp. 131-133. 10.1016/j.rmed.2016.10.007 .

http://ift.tt/2fgd7w3